Clinical Trial Update: NTX-301 in MDS/AML [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for NTX-301 in acute myeloid leukemia and myelodysplastic syndromes, including chronic myelomonocytic leukemia. The study is curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes
• Myelomonocytic Leukemia

Drugs mentioned

• NTX-301

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Acute Myeloid Leukemia, Myelodysplastic Syndromes | Phase 1 | Status: ACTIVE_NOT_RECRUITING